Univariate analysis for predictors of recanalization after thrombolysis
| Recanalized (n = 13) | Not Recanalized (n = 10) | P Value | |
|---|---|---|---|
| Mean ipsilateral MCA CBF (ml/100 g/min) | 20.2 ± 6.3 | 14.7 ± 5.3 | .039* |
| Mean contralateral MCA CBF (ml/100 g/min) | 39.8 ± 9.5 | 38.5 ± 10.1 | .74* |
| Ratio | 0.53 ± 0.19 | 0.38 ± 0.09 | .019* |
| Platelet count (×109/L) | 234 ± 74 | 324 ± 188 | .12* |
| Age (years) | 66.7 ± 12 | 67.7 ± 11 | .69* |
| Time-to-treatment (min) | 212 ± 59 | 222 ± 32 | .7* |
| NIHSS | 18 ± 3 | 17.69 ± 4 | .74* |
| Thrombus at carotid terminus | Yes: 4/23 | Yes: 3/23 | .68† |
| No: 9/23 | No: 7/23 | ||
| Mean arterial pressure (mm Hg) | 102 ± 21 | 105 ± 17 | .39* |
| Admission glucose | 141.8 ± 60 | 131.3 ± 50 | .63† |
| Thrombolytic modality | IA: 6/23 | IA: 5/23 | .60† |
| IV/IA: 7/23 | IV/IA: 5/23 | ||
| Antiplatelet therapy before admission | Yes: 2/23 | Yes: 4/23 | .34† |
| No: 11/23 | No: 6/23 | ||
| Stroke cause | CE: 6/23 | CE: 5/23 | .59† |
| Non-CE: 7/23 | Non-CE: 5/23 | ||
| Symptomatic hemorrhage | Yes: 4 /23 | Yes: 2/23 | .66 |
| No: 9/23 | No: 7/23 |
Note:—MCA indicates middle cerebral artery; CBF cerebral blood flow; NIHSS, National Institutes of Health Stroke Score; IA, intra-arterial; IV, intravenous; CE, cardioembolic; Non-CE, noncardioembolic.
*
Student t test.
†
Fisher exact test.